Filter
48
Filtered Results: 48
Text search:
Gaziano,
T.
et
al.
Featured
Recommendations
5
New Publications
5
Language
Document type
Studies & Reports
26
No document type
12
Guidelines
8
Situation Updates
1
Strategic & Response Plan
1
Countries / Regions
Argentina
3
South Africa
3
Brazil
3
North America
2
Chile
1
Mozambique
1
Italy
1
Global
1
Africa
1
Latin America and the Carribbean
1
Authors & Publishers
Publication Years
Category
Public Health
14
Countries
11
Clinical Guidelines
5
Key Resources
2
Capacity Building
1
Women & Child Health
1
Toolboxes
NCDs
17
COVID-19
4
TB
3
Planetary Health
3
Mental Health
2
HIV
2
Caregiver
2
Natural Hazards
1
Ebola
1
Pharmacy
1
NTDs
1
Typhoon
1
AMR
1
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
The Resolution Population and Individual Approaches to the Prevention and Management of Diabetes and Obesity was approved by the 48th Directing Council of the Pan American Health Organization, September 29- October 3, 2008, in response to the epidemic of obesity and diabetes currently affecting the ...
Since 2016, the Pan American Health Organization (PAHO) has been promoting the implementation of the HEARTS Initiative in the Americas as a regional adaptation of the World Health Organization's Global HEARTS Initiative. During this time, 33 countries in the Region of the Americas have committed to ...
Obesity and diabetes are affecting the peoples of the Americas at high and increasing rates. National surveys demonstrate that obesity is increasing in prevalence among all age groups; 7% to 12% of children under 5 years old and
one-fi fth of adolescents are obese, while rates of overweight and obe...
Accessed: 08.11.2020
The role of environmental contamination in transmission of COVID-19 virus is currently not clear. This protocol has been designed to determine (viable) virus presence and persistence on fomites in various locations where a patient infected with COVID-19 is currently receiving care or being isolated,...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Características farmacológicas y clínicas más relevantes de los Medicamentos Esenciales utilizados en el manejo de las enfermedades infecciosas prevalentes en el primer nivel de atención. La misma se agrupa a su vez en: antibióticos, antimicóticos, antivirales, antiparasitarios y fármacos pa...
